<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03438422</url>
  </required_header>
  <id_info>
    <org_study_id>PJK-W10</org_study_id>
    <nct_id>NCT03438422</nct_id>
  </id_info>
  <brief_title>Effect of Pollen Extract on Urinary Incontinence</brief_title>
  <official_title>Evaluation of the Impact of 3 Pollen Extracts in the Control of Urinary Incontinence in Women. Double-blind, Randomized, Placebo-controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr. Santiago Palacios</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto Palacios</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study with food supplement to assess the eficacy of pollen extract on Urinary Incontinence
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 21, 2017</start_date>
  <completion_date type="Anticipated">September 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">July 30, 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of the pollen extract on Urinary Incontinence</measure>
    <time_frame>Baseline, two and three months</time_frame>
    <description>To evaluate the effect of different pollen extracts on the number of leaks and on the amount of urine in each escape</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Urinary Incontinence</condition>
  <arm_group>
    <arm_group_label>GROUP A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 tablet a day of pollen A extract containing (140 mg aqueous extract and 8mg lipid purified pollen, aqueous extract pumpkin seed 300mg, 10mg Vitamin E)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GROUP B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 tablet a day of pollen B extract containing (140 mg aqueous extract and lipid 8 mg of purified pollen)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GROUP C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 tablet a day of pollen extract C containing (Pollen extract 160 mg, pumpkin seed extract, 300 mg and Vitamin E 10 mg)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PLACEBO</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>1 tablet a day of placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Pollen extract</intervention_name>
    <description>1 tablet a day</description>
    <arm_group_label>GROUP A</arm_group_label>
    <arm_group_label>GROUP B</arm_group_label>
    <arm_group_label>GROUP C</arm_group_label>
    <arm_group_label>PLACEBO</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Moderate, severe or very severe urinary incontinence, according to the severity index
             Incontinence Severity Index (ISI) * of Sandvik

          -  Healthy patients from 18 to 75 years of age

          -  Normal cytology in the last year and normal urological culture at inclusión

          -  Negative result in urine culture and normal vaginal canal (no evidence of dysplasia
             and / or infection)

          -  External vaginal area (vestibule and introitus) free of wounds or bleeding

        Exclusion Criteria:

          -  Surgery for urinary incontinence

          -  Acute or recurrent infections of the urinary tract or genital infections (herpes or
             candida) in the last 3 months

          -  Malignant neoplasm or history of neoplasia in the last 5 years

          -  Concomitant disease such as a cardiac disorder, uncontrolled type I or II diabetes,
             lupus porphyria, relevant neurological disorders, any disease that in the opinion of
             the doctor could interfere with the treatment or resolution of the disease

          -  Anticoagulant alteration or thromboembolic alteration or taking anticoagulant drugs
             one week before treatment or during treatment for possible drug interaction (to allow
             inclusion, temporary cessation of use at the discretion of the doctor)

          -  History of immunosuppression or immunodeficiency (including HIV infection or AIDS) or
             use of immunosuppressive medications

          -  Hormonal imbalance, related to the thyroid, hypophysis or androgen not controlled

          -  Having a significant alteration in the areas under treatment or inflammatory
             alterations including but not limited to lacerations, abrasions or ulcers prior to
             treatment (time of resolution at the discretion of the doctor) or during treatment

          -  Dysplastic nevus in the treatment área

          -  Prolapse grade II according to the classification of the &quot;Pelvic Organ Prolapse
             Quantification (ICS-POP-Q) System&quot;

          -  Kegel exercises or electrostimulation at least 30 days before the start of treatment
             are not allowed
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Women</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Santiago Palacios, MD</last_name>
    <phone>+314 91 578 05 17</phone>
    <email>investigacion@institutopalacios.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Eva Soler, SC</last_name>
    <phone>+ 34 91 578 05 17</phone>
    <email>eva.maria.soler@institutopalacios.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Instituto Palacios</name>
      <address>
        <city>Madrid</city>
        <zip>28009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Santiago Palacios, PI</last_name>
      <phone>+34 91 578 05 17</phone>
      <email>investigacion@institutopalacios.com</email>
    </contact>
    <contact_backup>
      <last_name>Eva M Soler, SC</last_name>
      <phone>+34 91 578 05 17</phone>
      <email>eva.maria.soler@institutopalacios.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 8, 2018</study_first_submitted>
  <study_first_submitted_qc>February 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 19, 2018</study_first_posted>
  <last_update_submitted>February 16, 2018</last_update_submitted>
  <last_update_submitted_qc>February 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Instituto Palacios</investigator_affiliation>
    <investigator_full_name>Dr. Santiago Palacios</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

